Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05908799 · ClinicalTrials.gov registry record
Emulation of the KEYNOTE-189 Trial Using Electronic Health Records
A clinical trial, sponsored by Aetion.
- Completed
- Registry status
- 1,854
- Enrollment target
NCT05908799 is a clinical trial that has completed, run by Aetion. The registered enrollment target is 1,854 participants.
The verdict
NCT05908799 has completed, sponsored by Aetion.
- COMPLETED
- Registry status
- 1,854 participants
- Enrollment target
Study Summary
Investigators are building an empirical evidence base supporting the utility of real-world data through the emulation of randomized controlled trials in the oncology setting. The purpose of this work is to demonstrate whether real-world evidence studies can provide reliable conclusions on treatment effectiveness to inform further applications of real-world data in pharmaceutical product label expansion, post-marketing safety, and other purposes that are complementary to RCTs.
Interventions
- DRUG Pembrolizumab + Pemetrexed-Platinum
- DRUG Pemetrexed-Platinum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,854 participants |
| Start Date | 2023-06-05 |
| Est. Completion | 2023-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05908799
The ClinicalTrials.gov registry entry for NCT05908799 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,854 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aetion, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pembrolizumab + Pemetrexed-Platinum is the first listed.
NCT05908799 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05908799 about?
NCT05908799 is a clinical study titled "Emulation of the KEYNOTE-189 Trial Using Electronic Health Records". Investigators are building an empirical evidence base supporting the utility of real-world data through the emulation of randomized controlled trials in the oncology setting. The purpose of this work is to demonstrate whether real-world evidence studies can provide reliable conclusions on treatment ...
What is the current status of trial NCT05908799?
This trial is currently completed. The enrollment target is 1,854 participants. The study started on 2023-06-05. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT05908799?
The interventions under investigation include: Pembrolizumab + Pemetrexed-Platinum (DRUG), Pemetrexed-Platinum (DRUG).
Who is sponsoring clinical trial NCT05908799?
This trial is sponsored by Aetion, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.